Pay Range

Company Overview

The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. One of the world's most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 30 years.

Vaccination for COVID-19 and Influenza (flu) is mandatory for all MSK staff. Staff are considered fully vaccinated upon completion of a primary vaccination series for COVID-19 (i.e., one dose of a single dose vaccine or a final dose of a multi-dose vaccine series). Exceptions from the COVID-19 and Influenza (flu) vaccine requirements are permitted for those who request and receive an approved medical, religious, or fully remote exemption. Requests for exemption can take up to two weeks to review. Vaccination or an approved exemption is required to start work.

Job Description

We are looking for an experienced technology transfer professional and highly driven innovator engaged in the ecosystem of venture capital, corporate spinouts, and investments at the intersection of healthcare, pharma and information technology.

You will:

• Lead strategic and transactional aspects of major tech transfer / IP licensing transactions and other business development activities, including an oncology accelerator program
• Draft, negotiate and execute an array of contracts for multiple client engagements, merging early stage and large pharma business perspectives, digital health technologies and world renown oncology research
• Work with companies at all stages across the capital lifecycle to apply your industry knowledge
• Identify and structure collaboration opportunities and shepherd engagements through all elements of their lifespan
• Craft MSK's growing digital health capabilities via providing thought leadership alongside industry luminaries
• Drive the end-to-end deal process; maintaining close relationships with MSK and partner executive leadership

You have:

• 5 years of relevant healthcare technology experience
• Direct contracting experience related to technology transfer, IP licensing, mergers, acquisitions, or investments
• Program management experience in a sophisticated, technical environment
• Excellent judgment, as well as organizational and communication skills
• Prior experience in healthcare/pharmaceutical startups or spinouts, venture capital, technical business development in healthcare technology, especially oncology-specific is highly preferred

#LI-HYBRID - 2 days onsite at 633 Third Avenue, NY

Are you ready to learn more about our Benefits?

Pay Range $129,500.00-$213,800.00

Please click to learn more about MSK's compensation philosophy.

Closing

MSK is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply and will receive consideration without regard to race, color, gender, gender identity or expression, sexual orientation, national origin, age, religion, creed, disability, veteran status or any other factor which cannot lawfully be used as a basis for an employment decision.

Federal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. Please tell us if you require a reasonable accommodation to apply for a job or to perform your job. Examples of reasonable accommodation include making a change to the application process or work procedures, providing documents in an alternate format, using a sign language interpreter, or using specialized equipment.